Neurogenic bladder following spinal cord injury

Spinal Cord Medicine: Second Edition

Volumn , Issue , 2011, Pages

  Linsenmeyer, Todd A ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b KESSLER INSTITUTE FOR REHABILITATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883353894     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (194)

1. Grant JCB. An atlas of anatomy. 6th ed. Baltimore, MD: Williams & Wilkins, 1972:181-189.
2. Olsson CA. Anatomy of the upper urinary tract. In: Walsh PC, Gittes RF, Perlmutter AD, et al., eds. Campbell's urology. 5th ed. Philadelphia, PA: WB Saunders, 1986:12-29.
3. Kaye KW, Goldberg ME. Applied anatomy of the kidneys and ureters. Urol Clin North Am 1982;9:3-13.
4. Tanago EA. Anatomy of the lower urinary tract. In: Walsh PC, Gittes RF, Perlmutter AD, et al., eds. Campbell's urology. 5th ed. Philadelphia, PA: WB Saunders, 1986:46-61.
5. Stephens FD, Lenaghan D. The anatomical basis and dynamics of vesicoureteral reflux. J Urol 1962;87:669-680.
6. Griffiths DJ, Notschaele C. Mechanics of urine transport in the upper urinary tract: 1. the dynamics of the isolated bolus. Neurourol Urodyn 1983;2:155-166.
7. Myers RP, Goellner JR, Cahill DR. Prostate shape, external striated urethral sphincter and radical prostatectomy: the apical dissection. J Urol 1987;138:543-547.
8. Delancey JO. Structure and function of the continence mechanism relative to stress incontinence. In: Leach GE, Paulson DF, eds. Problems in urology: Female urology, vol. 1. Philadelphia, PA: JB Lippincott, 1991:1-9.
9. Gosling JA, Dixon JS. Species variation in the location of upper urinary tract pacemaker cells. Invest Urol 1974;11:418-423.
10. Fletcher TF, Bradley WE. Neuroanatomy of the bladder-urethra. J Urol 1978;119:153-160.
11. Benson GS, McConnell JA, Wood JG. Adrenergic innervation of the human bladder body. J Urol 1979;122:189-191.
12. Elbadawi A. Autonomic muscular innervation of the vesical outlet and its role in micturition. In: Hinman F Jr, ed. Benign prostatic hypertrophy. New York, NY: Springer Verlag, 1983:330-348.
13. Burnstock G. The changing face of autonomic neurotransmission. Acta Physiol Scand 1986;126:67-91.
14. Norlen L, Dahlstrom A, Sundin T, et al. The adrenergic innervation and adrenergic receptor activity of the feline urinary bladder and urethra in the normal state and after hypogastric and/or parasympathetic denervation. Scand J Urol Nephrol 1976;10:177-184.
15. Elbadawi A. Ultrastructure of vesicourethral innervation: III. axoaxonal synapses between postganglionic cholinergic axons and probably SIF-cell derived processes in feline lissosphincter. J Urol 1985;133:524-528.
16. Chancellor MB, De Groat WC. Intravesical capsaicin and resiniferatoxin therapy. J Urol 1999;162: 3-11.
17. de Groat, WC. Mechanism underlying the recovery of lower urinary tract function following spinal cord injury. Paraplegia 1995;33:493-505.
18. Elbadawi A, Schenk EA. A new theory of the innervation of bladder musculature: part 4. Innervation of the vesicourethral junction and external urethral sphincter. J Urol 1974;111:613-615.
19. Sundin T, Dahlstrom A. The sympathetic innervation of the urinary bladder and urethra in the normal state and after parasympathetic denervation at the spinal root level. Scand J Urol Nephrol 1973;7:131-149.
20. Crowe R, Burnstock G, Light JK. Adrenergic innervation of the striated muscle of the intrinsic external urethral sphincter from patients with lower motor spinal cord lesion. J Urol 1989;141:47-49.
21. Denny-Brown D, Robertson EG. On the physiology of micturition. Brain 1933;56:149-190.
22. Barrington FJF. The relation of the hindbrain to micturition. Brain 1921;44:23-53.
23. Bradley WE. Physiology of the urinary bladder. In: Walsh PC, Gittes RF, Perlmutter AD, et al., eds. Campbell's urology. 5th ed. Philadelphia, PA: WB Saunders, 1986:129-185.
24. Carlsson CA. The supraspinal control of the urinary bladder. Acta Pharmacol Toxicol 1978;43A(Suppl II):8-12.
25. Bradley WE, Teague CT. Spinal cord organization of micturitional reflex afferents. Exp Neurol 1968;22:504-516.
26. Barrett DM, Wein AJ. Voiding dysfunction: diagnosis, classification and management. In: Gillenwater JY, Grayhack JT, Howards SS, et al., eds. Adult and pediatric urology. 2nd ed. St Louis, MO: Mosby Year Book, 1991:1001-1099.
27. Comarr AE. Diagnosis of the traumatic cord bladder. In: Boyarsky S, ed. The neurogenic bladder. Baltimore, MD: Williams & Wilkins, 1967:147-152.
28. Bradley WE, Chou S, Markland C. Classifying neurologic dysfunction of the urinary bladder. In: Boyarsky S, ed. The neurogenic bladder. Baltimore, MD: Williams & Wilkins, 1967:139-146.
29. Lapides J. Neuromuscular vesical and ureteral dysfunction. In: Campbell MF, Harrison JH, eds. Urology. 3rd ed. Philadelphia, PA: WB Saunders, 1970:1343-1379.
30. Wein AJ. Classification of neurogenic voiding dysfunction. J Urol 1981;125:605-609.
31. Abrams P, Cardozo L, Fall M, et al. The Standardisation of Terminology of Lower Urinary Tract Function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-178.
32. Biering-Sørensen F, Craggs M, Kennelly M, et al. International Urodynamic Basic Spinal Cord Injury Data Set. Spinal cord. advance online publication, January 29, 2008; doi:10.1038/sj.sc.3102174.
33. Kaplan SA, Chancellor MB, Blaivas JG. Bladder and sphincter behavior in patients with spinal cord lesions. J Urol 1991;146:113-117.
34. Yalla SV, Fam BA. Spinal cord injury. In: Krane RJ, Siroky MB, eds. Clinical neuro-urology. 2nd ed. Boston, MA: Little, Brown & Co, 1991:319-331.
35. Rudy DC, Awad SA, Downie JW. External sphincter dyssynergia: an abnormal continence reflex. J Urol 140:105-110.
36. Light JK, Faganel J, Beric A. Detrusor areflexia in suprasacral spinal cord injuries. J Urol 1985;134:295-297.
37. Graham SD. Present urological treatment of spinal cord injury patients. J Urol 1981;126:1-4.
38. Downie JW, Awad SA. The state of urethral musculature during the detrusor areflexia after spinal cord transection. Inv Urol 1979;17:55-59.
39. Nanninga JB, Meyer P. Urethral sphincter activity following acute spinal cord injury. J Urol 1980;123:528-530.
40. Koyanagi T, Arikado K, Takamatsu T, et al. Experience with electromyography of the external urethral sphincter in spinal cord injury patients. J Urol 1982;127:272-276.
41. Blaivas JG, Sinha HP, Zayed AAH, Labib KB. Detrusor-external sphincter dyssynergia. J Urol 1981;125:542-544.
42. Pavlakis AJ, Siroky MB, Goldstein I, et al. Neurourologic findings in conus medullaris and cauda equina injury. Arch Neurol 1983;40:570-573.
43. Sharr MM, Carfield JC, Jenkins JD. Lumbar spondylosis and neuropathic bladder investigations of 73 patients with chronic urinary symptoms. Br Med J 1976;1:645.
44. Hackler RH, Hall MK, Zampieri TA. Bladder hypocompliance in the spinal cord injury population. J Urol 1989;141:1390-1393.
45. Sislow JG, Mayo ME. Reduction in human bladder wall compliance following decentralization. J Urol 1990;144:945-947.
46. Appell RA, Whiteside HV. Diabetes and other peripheral neuropathies affecting lower urinary tract function. In: Krane RJ, Siroky MG, eds. Clinical neuro-urology. 2nd ed. Boston, MA: Little, Brown & Co, 1991:365-373.
47. Bradley WE. Autonomic neuropathy and the genitourinary system. J Urol 1978;119:299-302.
48. Andersen JT, Bradley WE. Abnormalities of bladder innervation in diabetes mellitus. Urology 1976;7:442-448.
49. Wheeler JS Jr, Siroky MB, Pavlakis A, et al. The urodynamic aspects of the Guillain-Barre syndrome. J Urol 1984;131:917-919.
50. Wyndaele JJ. Correlation between clinical neurological data and urodynamic function in spinal cord injured patients. Spinal Cord 1997;35:213-216.
51. Linsenmeyer TA, Culkin D. APS Recommendations for the urological evaluation of patients with spinal cord injury. J Spinal Cord Med 1999;22(2):139-142.
52. Linsenmeyer TA, Chou F, Millis S, et al. Long-term change in bladder function following SCI. J Spinal Cord Med 2001;24:196(abst).
53. Bih LI, Changlai SP, Ho CC, et al. Application of radioisotope renography with technetium-99m mercaptoacetyltriglycine on patients with spinal cord injuries. Arch Phys Med Rehabil 1994;75:982-986.
54. Phillips JR, Jadvar H, Sullivan G, et al. Effect of radionuclide renograms on treatment of patients with spinal cord injuries. AJR Am J Roentgenol 1997;169:1045-1047.
55. Kuhlemeier KV, McEachran AB, Lloyd LK, et al. Serum creatinine as an indicator of renal function after spinal cord injury. Arch Phys Med Rehabil 1984;65:694-697.
56. Rao KG, Hackler RH, Woodlief RM, et al. Real time renal sonography in spinal cord injury patients: prospective comparison with excretory urography. J Urol 1986;135:72-77.
57. Tsai SJ, Ting H, Ho CC, et al. Use of sonography and radioisotope renography to diagnose hydronephrosis in patients with spinal cord injury. Arch Phys Med Rehabil 2001;82:103-106.
58. Liu W, Esler SJ, Kenny BJ, et al. Low-dose nonenhanced helical CT of renal colic: assessment of ureteric stone detection and measurement of effective dose equivalent. Radiology 2000;215:51-54.
59. Linsenmeyer TA, Campagnolo DI, Chou I. Silent autonomic dysreflexia during voiding in men with SCI. J Urol 1996;155:519-522.
60. Pannek J, Nehiba M. Morbidity of urodynamic testing in patients with spinal cord injury: is antibiotic prophylaxis necessary? Spinal Cord 2007;45:771-774.
61. Khanna OP. Cystometry: water. In: Barrett DM, Wein AJ, eds. Controversies in neuro-urology. New York, NY: Churchill-Livingston, 1984:11-12.
62. Lapides J, Friend CR, Ajemian EP, et al. A new Test for neurogenic bladder. J Urol 1962;88:245-247.
63. Wheeler JS Jr, Culkin DJ, Canning JR. Positive bethanechol supersensitivity test in neurologically normal patients. Urology 1988:31:89-99.
64. McGuire EJ, Woodside JR, Borden TA, et al. Prognostic value of urodynamic testing in myelodysplastic patients. Problems Urol 1981;126:205-209.
65. Bauer SB. Urologic management of the myelodysplastic child. Probl Urol 1989;3:86-101.
66. Brown JH. Atropine, scopolamine and related antimuscarinic drugs. In: Gilman AG, Rall TW, Nies AS, et al., eds. Goodman and Gilman's the pharmacologic basis of therapeutics. 8th ed. New York, NY: Pergamon Press, 1990:150-165.
67. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Gillman AG, Rall TW, Nies AS, et al., eds. Goodman and Gilman's the pharmacologic basis of therapeutics. 8th ed. New York, NY: Pergamon Press, 1990:383-435.
68. Yokoyama O, Komatsu K, Kodama K, et al. Diagnostic value of intravesical lidocaine for overactive bladders. J Urol 2000;164(2):340-343.
69. Brendler CB, Radebaugh LC, Mohler JL. Topical oxybutynin chloride for relaxation of dysfunctional bladder.J Urol 1989;141:1350-1352.
70. Vaidyananthan S, Soni BM, Brown E, et al. Effect of intermittent urethral catheterization and oxybutynin bladder instillation on urinary continence status and quality of life in a selected group of spinal cord injured patients with neuropathic bladder dysfunction. Spinal Cord 1998;36:409-414.
71. Haferkamp A, Saehhler G, Gerner HJ, et al. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients. J Spinal Cord 2000;38:250-254.
72. de Seze M, Wiart L, Joseph PA, et al. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 1998;17:513-523.
73. Silva C, Rio M, Cruz F. desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Eur Urol 2000;38:444-452.
74. Silva C, Silva J, Ribeiro MJ, et al. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial. Eur Urol 2005;48:650-655.
75. Giannantoni A, Di Satasi SM, Stephen RL, et al. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol 2002;167:1710-1714.
76. Schurch B, Stohrer M, Kramer G, et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000;164:692-697.
77. Apostolidis A, Popat R, Yiangou Y, et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005;174:977-982.
78. Karsenty G, Denys P, Amarenco G, et al. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactivc bladder: a systematic literature review. Eur Urol 2008;53:275-287.
79. Consortium for Spinal Cord Medicine. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers. J Spinal Cord Med 2006;29:527-573.
80. Guttmann L, Frankel H. The value of intermittent catheterization in the early management of traumatic paraplegia and tetraplegia. Paraplegia 1966/1967;4:63-84.
81. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self catheterization in treatment of urinary tract disease. J Urol 1972;107:458-461.
82. Maynard FM, Glass J. Management of the neuropathic bladder by clean intermittent catheterisation: 5 year outcomes. Paraplegia 1987;25:106-110.
83. Yavuzer, Gok H, Tuncer W, et al. Compliance with bladder management in spinal cord injury patients. Spinal Cord 2000;38:762-765.
84. CMS Manual SYSTEM PB 100-07 State Operations Providers Certification Department of Health and Human Services (DHHS) Centers for Medicare and Medicaid Services (CMS) June 28 2005. page 17
85. Weld KJ, Dmochowski RR. Effect of Bladder management on urological complications in Spinal cord injured patients. J Urol 2000;163:768-772.
86. Feifer A, Corcos J. Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients. Neurourol Urodyn 2008;27:475-479.
87. Drake MJ, Cortina-Borja M, Savic G, et al. Prospective evaluation of urological effects of aging in chronic spinal cord injury by method of bladder management. Neurourol Urodyn 2005;24:111-116.
88. Dewire DM, Owens RS, Anderson GA, et al. A comparison of the urological complications associated with long term management of quadriplegics with and without chronic indwelling urinary catheters. J Urol 1992;147:1060-1072.
89. Kaufman JM, Fam B, Jacobs SC, et al. Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 1977;118:967-971.
90. Kalisvaart JF, Katsumi HK, Ronningen LD, et al. Bladder cancer in spinal cord injury patients. Spinal Cord Med 2010;48:257-261.
91. Subramonian K, Cartwright RA, Harnden P, Harrison SC, Bladder cancer in patients with spinal cord injuries. BJU Int 2004;93(6):739-743.
92. Mitsui T, Minami K, Furuno T, et al. Is suprapubic cystostomy an optimal urinary management in high quadriplegics? A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol 2000;38:434-438.
93. Kim YH, Katten MW, Boone TB. Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detrusor-sphincter dyssynergia. J Urol 1998;159:493-497.
94. Killorin W, Gray M, Bennet JK, et al. The value of urodynamics and bladder management in predicting upper urinary tract complications in male spinal cord injury patients. Paraplegia 1992;30:437-441.
95. Gerridzen RG, Thijssen AM, Dehoux E. Risk factors for upper tract deterioration in chronic spinal cord injury patients. J Urol 1992;147:416-418.
96. Linsenmeyer TA, Bagaria SP, Gendron B. The impact of urodynamic parameters on the upper tracts of spinal cord injured men who void reflexly. J Spinal Cord Med 1998;21:15-20.
97. Gray GJ, Yang C. Surgical procedures of the bladder after spinal cord injuries. Top Spinal Cord Med 2000;11:61-69.
98. MacDougal WS. Metabolic and neuromechanical problems of urinary intestinal diversions. In Walsh PC, Retik AB, Vaughan ED, Wein AJ, eds. Campbells urology. 8th ed. Philadelphia, PA: WB Saunders Co., 2002;3777-3783.
99. Golomb J, Klutke CG, Lewin KJ, et al. Bladder neoplasms associated with augmentation cystoplasty: report of 2 cases and literature review. J Urol 1989;142:377-380.
100. Stein JP, Skinner D. Techniques of orthotopic bladder substitutes. In: Walsh PC, Retik AB, Vaughan ED, et al., eds. Campbells urology, 8th ed, Philadelphia, PA: WB Saunders Co., 2002:3849-3851.
101. Mast P, Hoebeke P, Wyndaele JJ, et al. Experience with augmentation cystoplasty: a review. Paraplegia 1995;33:560-564.
102. Kuo HC. Clinical outcomes and quality of life after enterocystoplasty for contracted bladders. Urol Int 1997;58:160-165.
103. Stohrer M, Kramer G, Gopel M, et al. Bladder autoaugmentation in adult patients with neurogenic voiding dysfunction. Spinal Cord 1997;35:456-462.
104. Atala A, Bauer SB, Soker S, et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006;367:1241-1246.
105. Anderson B, Mitchell M. Management of electrolyte disturbances following urinary diversion and bladder augmentation. AUA News 2000;5:1-7.
106. Misak SJ, Bunts RC, Ulmer JL, Eagles WM. Nerve interruption procedures in the urologic management of paraplegic patients. J Urol 1962;88:392.
107. Leach GE, Goldman D, Raz S. Surgical treatment of detrusor hyperreflexia. In: Raz S, ed. Female urology. Philadelphia, PA: WB Saunders, 1983:326-334.
108. Hodgkinson CP, Drukker BH. Infravesical nerve resection for detrusor dyssynergia: the Ingelman-Sundberg operation. Acta Obstet Gynecol Scand 1977;56:401-408.
109. Ohlsson BL, Frankenberg-Sommar S. Effects of external and direct pudendal nerve 110 maximal electrical stimulation in the treatment of the uninhibited overactive bladder. Br J Urol 1989;64:374-380.
110. Tanago EA. Concepts of neuromodulation. Neurourol Urodyn 1993;12:497-498.
111. Brindley GS, Polkey CE, Rushton DN. Sacral anterior root stimulator for bladder control in paraplegia. Paraplegia 1982;20:365-381.
112. Creasey GH, Bodner DR. Review of sacral electrical stimulation in the management of the neurogenic bladder. NeuroRehabilitation 1994;4:266-274.
113. Van Kerrebroeck PEV. World wide experience with the Finetech-Brindley sacral anterior root stimulator. Neurourol Urodyn 1993;12:497-503.
114. Kegel AH. Progressive resistance exercises in the functional restoration of the perineal muscles. Am J Obstet Gynecol 1948;56:238-248.
115. Wyndaele JJ. Pharmacotherapy for urinary bladder dysfunction in spinal cord injury patients. Paraplegia 1990;28:146-150.
116. Hoffman BB, Lefkowitz RJ. Catecholamines and sympathomimetic drugs. In: Gillman AG, Rall TW, Nies AS, et al., eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York, NY: Pergamon Press, 1990:187-220.
117. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke.N Engl J Med 2000;343:1826.
118. Pickard R, Reaper J, Wyness L, et al. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2003;(2):CD003881.
119. Mitterberger M, Marksteiner R, Margreiter E, et al. Autologous myoblasts and fibroblasts for female stress incontinence: a 1-year follow-up in 123 patients. BJU Int 2007;100:1081-1085.
120. Light JK, Scott FB. Use of the artificial urinary sphincter in spinal cord injury patients. J Urol 1983;130:1127-1129.
121. Kelly MJ, Leach GE. Long term results of bladder neck suspension procedures. Probl Urol 1991;5:94-105.
122. Opitz JL. Treatment of voiding dysfunction in spinal cord injured patients: bladder retraining. In: Barrett DM, Wein AJ, eds. Controversies in neuro-urology. New York, NY: Churchill-Livingston, 1984:437-451.
123. Barbalias GA, Klauber GT, Blaivas JG. Critical evaluation of the Crede maneuver: a urodynamic study of 207 patients. J Urol 1983;130:720-723.
124. Finkbeiner AE. Is bethanechol chloride clinically effective in promoting bladder emptying? A literature review. J Urol 1985;134:443-449.
125. Light KJ, Scott FB. Bethanechol chloride and the traumatic cord bladder. J Urol 1982;128:85-87.
126. Sporer A, Leyson JFJ, Martin BF. Effects of bethanechol chloride on the external urethral sphincter in spinal cord injury patients. J Urol 1978;120:62-66.
127. Taylor P. Cholinergic agonists. In: Gilman AC, Rall TW, Nies AS, et al., eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York, NY: Pergamon Press, 1990:122-130.
128. Vaidyanathan S, Rao MS, Mapa MK, et al. Study of intravesical instillation of 1A(s)-15 methy prostaglandin F2 in patients with neurogenic bladder dysfunction. J Urol 1981;126:81-85.
129. Booth AM, Hisamitsu T, Kawatani M, et al. Regulation of urinary bladder capacity by endogenous opioid peptides. J Urol 1985;133:339-342.
130. Xiao C, Du M, Li B, et al. An artificial somatic-autonomic reflex pathway procedure for bladder control in children with spina bifida. J Urol 2005;173(6):2112-2116.
131. Wood D. Southgate current status of tissue engineering in urology. Curr Opin Urol 2008;18(6):564-569.
132. Lockhart JL, Vorstman B, Weinstein D, et al. Sphincterotomy failure in neurogenic bladder disease. J Urol 1986;135:86-89.
133. Ninkovic M, Stenzl A, Schwabegger A, et al. Free neurovascular transfer of latisstmus dorsi muscle for the treatment of bladder acontractility: II. Clinical results. J Urol 2003;169(4):1379-1383.
134. Maizels M, King LR, Firlit CR. Urodynamic biofeedback: a new approach to treat vesical sphincter dyssynergia. J Urol 1979;122:205-209.
135. Kiviat MD, Zimmermann TA, Donovan WH. Sphincter stretch: new technique resulting in continence and complete voiding in paraplegics. J Urol 1975;114:895-897.
136. Lepor H. Alpha blockers for the treatment of benign prostatic hypertrophy. Probl Urol 1991;5:419-429.
137. Scott MB, Morrow JW. Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury: I. Voiding dysfunction. J Urol 1978;119:480-482.
138. Lepor H, Gup DI, Baumann M, et al. Laboratory assessment of terazosin and alpha 1 blockade in prostatic hyperplasia. Urology 1988;32(Suppl 6):21-26.
139. Scott MB, Morrow JW. Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury: II. Autonomic dysreflexia. J Urol 1978;119:483-484.
140. Hoffman BB, Lefkowitz RJ. Adrenergic receptor antagonists. In: Gilman AG, Rall TW, Nies AS, et al., eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York, NY: Pergamon Press, 1990:221-243.
141. Wein AJ. Prazosin in the treatment of prostatic obstruction: a placebo controlled study (editorial comment).J Urol 1989;141:693.
142. Dykstra DD, Sidi AA, Scott AB, et al. Effects of botulinum A toxin on detrusor sphincter dyssynergia in spinal cord injury patients. J Urol 1988;139:919-922.
143. Schurch B, Hauri B, Rodic A, et al. Botulinum-A toxin as a treatment of detrusor sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996;155:1023-1029.
144. Chancellor MB, Rivas DA, Linsenmeyer T, et al. Multicenter trial in North America of Urolume urinary sphincter prosthesis. J Urol 1994;152:924-930.
145. Hamid R, Arya M, Patel HR, et al. The mesh wallstent in the treatment of detrusor external sphincter dyssynergia in men with spinal cord injury: a 12-year follow-up. BJU Int 2003;91:51-53.
146. Perkash I. Modified approach to sphincterotomy in spinal cord injury patients. Paraplegia 1976;13:247-260.
147. Yang CC, Mayo ME. External sphincterotomy; long term follow up. Neurourol Urodyn 1995;14:25-31.
148. Bosco PJ, Bauer SB, Colodny AH, et al. The long term results of artificial sphincters in children. J Urol 1991;146:396-399.
149. Parres JA, Kropp KA. Urodynamic evaluation of the continence mechanism following urethral lengthening: reimplantation and enterocystoplasty. J Urol 1991;146:535-538.
150. Nabet G, Kasabian MD; Stuart B, et al. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 1992;146:840-843..
151. Enrile BG, Crooks KK. Clean intermittent catheterization in children with myelodysplasia. Clin Pediatr 1980;19:743-745.
152. Lloyd LK, Kuhlemeier KV, Fine PR, et al. Initial bladder management in spinal cord injury: does it make a difference? J Urol 1986;135:523-527.
153. Maynard FM, Diokno AC. Urinary infection and complications during clean intermittent catheterization following spinal cord injury. J Urol 1984;132:943-946.
154. Romano JM, Kaye D. UTI in the elderly: common yet atypical. Geriatrics 1981;36:113-120.
155. Kass EH. The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: Quinn EL, Kass EH, eds. Biology of pyelonephritis. Boston, MA: Little, Brown & Co, 1960:399-418.
156. Stamey TA. Recurrent urinary tract infections in female patients: an overview of management and treatment. Rev Infect Dis 1987; 9(Suppl 2):S195-S210.
157. Stamm WE, Counts GW, Running KR, et al. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982;307:463-468.
158. Rhame FS, Perkash I. Urinary tract infections occurring in recent spinal cord injury patients on intermittent catheterization. J Urol 1979;122:669-673.
159. Donovan WH, Stolov WC, Clowers DE, et al. Bacteriuria during intermittent catheterization following spinal cord injury. Arch Phys Med Rehabil 1978;59:351-357.
160. National Institute on Disabilities and Rehabilitation Research. The prevention and management of urinary tract infections among people with spinal cord injuries; Consensus Conference Statement. January 27-29, 1992. J Am Paraplegia Soc 1992;15:194-204.
161. Deresinski SC, Perkash I. Urinary tract infections in male spinal cord injured patients: part 2. Diagnostic value of symptoms and of quantitative urinalysis. J Am Paraplegia Soc 1985;8:7-10.
162. Anderson RU, Hsieh-ma ST. Association of bacteriuria and pyuria during intermittent catheterization after spinal cord injury. J Urol 1983;130:299-301.
163. Kass EJ, Koff SA, Diokno AC, et al. The significance of bacilluria in children on long term intermittent catheterization. J Urol 1981;126:223-225.
164. Lewis RI, Carrion HM, Lockhart JL, et al. Significance of asymptomatic bacteriuria in neurogenic bladder disease. Urology 1984;23:343-347.
165. Tempkin A, Sullivan G, Paldi J, et al. Radioisotope renography in spinal cord injury. J Urol 1985;133:228-230.
166. Anderson RU. Non sterile intermittent catheterization with antibiotic prophylaxis in the acute spinal cord injured male patient. J Urol 1980;124:392-394.
167. Merritt JLM, Erickson RP, Opitz JL. Bacteriuria during follow up in patients with spinal cord injury: Part II. efficacy of antimicrobial suppressants. Arch Phys Med Rehabil 1982;63:413-415.
168. Kuhlemeier KV, Stover SL, Lloyd LK. Prophylactic antibacterial therapy for preventing urinary tract infections in spinal cord injury patients. J Urol 1985;134:514-517.
169. Gillenwater JY. Hydronephrosis. In: Gillenwater JY, Grayhack JT, Howards SS, et al., eds. Adult and pediatric urology. 2nd ed. St. Louis, MO: Mosby Year Book, 1991:789-813.
170. Staskin DR. Hydroureteronephrosis after spinal cord injury. Urol Clin North Am 1991;18:309-316.
171. Teague N, Boyarsky S. Further effects of coliform bacteria on ureteral peristalsis. J Urol 1968;99:720-724.
172. Price M, Kottke FJ. Renal function in patients with spinal cord injury: the eighth year of a ten year continuing study. Arch Phys Med Rehabil 1975;56:76-79.
173. Fellows GJ, Silver JR. Long term follow up of paraplegic patients with vesico-ureteric reflux. Paraplegia 1976;14:130-134.
174. Winberg J. Urinary tract infections in infants and children. In: Walsh PC, Gittes RF, Perlmutter AD, et al., eds. Campbell's urology. 5th ed. Philadelphia, PA: WB Saunders, 1986:848-867.
175. Linsenmeyer TA, House JG, Mills SR. The role of abnormal congenitally displaced ureteral orifices in causing reflux following spinal cord injury, J Spinal Cord Med 2004;27(2):116-119.
176. Ponce Diaz-Reixa J, Sanchez Rod riguez-Losada J, Alvarez Castello L, et al. Vesicoureteral reflex in spinal cord injured patients. Treatment results and stastical analysis. Actas Urol Esp 2007;31(4):366-371.
177. DeVivo MJ, Fine PR. Predicting renal calculus occurrence in spinal cord injury patients. Arch Phys Med Rehabil 1986;67:722-725.
178. Burr RG. Urinary calculi composition in patients with spinal cord lesions. Arch Phys Med Rehabil 1978;59:84-87.
179. Griffith DP, Osborne CA. Infection(urease) stones. Miner Electrolyte Metab 1987;13:278-285.
180. Kuhlemeier KV, Lloyd LK, Stover SL. Long term followup of renal function after spinal cord injury. J Urol 1985;134:510-513.
181. Singh M, Chapman R, Tresidder GC, et al. Fate of unoperated staghorn calculus. Br J Urol 1973;45:581-585.
182. Donnellan SM, Bolton DM. The impact of contemporary bladder management techniques on struvite calculi associated with spinal cord injury. BJU Int 1999;84(3):280-285.
183. Irwin PP, Evans C, Chawla JC, et al. Stone surgery in the spinal patient. Paraplegia 1991;29:161-166.
184. Lam HS, Lingman JE, Barron M, et al. Staghorn calculi:analysis of treatment results between initial pericutaneous nephrolithotomy and extra corporeal shock lithotripsy momotherapy with reference to stone surface area. J Urol1992;147:1219-1225.
185. Preminger GM, Assimos DG, Lingeman JE, et al. AUA Nephrolithiasis Guideline Panel. AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 2005;173:1991-2000.
186. Peterson CM. Partial dissolution of struvite calculus with oral acetohydroxamic acid. Urology 1983;22:410-412.
187. DeVivo MJ, Fine PR, Cutter GR, et al. The risk of bladder calculi in patients with spinal cord injuries. Arch Intern Med 1985;145:428-430.
188. Linsenmeyer MA, Linsenmeyer TA. Accuracy of detecting bladder stones bases on abdominal x ray. J Spinal Cord Med 2004;27:438-442.
189. Linsenmeyer MA, Linsenmeyer TA. Accuracy of predicting bladder stones based on catheter encrustation in individuals with spinal cord injury. J Spinal Cord Med 2006;29:402-405.
190. Newman W, Jacobson AS. Paraplegia and secondary amyloidosis. Report of six cases. Am J Med 1953;15:216-222.
191. Thompson C, Rice M. Secondary amyloidosis in spinal cord injury. Ann Internal Med 1949;31(6):1057-1065.
192. Cengiz K. Uncommon Aetiology in renal amyloidosis. Acta Clinica Belgica 2005;59:109-113.
193. Lindermann RD, Scheer RLM, Raisz LG. Renal Amyloidosis. Ann Internal Med 1961;54:883.
194. Dikman HS, Kahn T, Gribetz D, et al. Resolution of renal amyloidosis. Am J Med 1977;63:430-433.